Is Whiting Petroleum Corp (WLL)’s Bull Run Going to Continue?

Whiting Petroleum Corp (NYSE:WLL) has seen a tremendous rise this year, returning an impressive 44% year to date, but can the company continue to outperform? FBN’s Charles Payne thinks so as Whiting Petroleum Corp (NYSE:WLL) is one of his top picks. He discussed the company’s outlook with Matt McCall, Founder of Penn Financial Group; retail analyst Hitha Prabhakar; Chief Strategist of Belpointe Asset Management, David Nelson and FBN’s Tracy Byrnes on Fox Business, recently.

Whiting Petroleum Corp (NYSE:WLL)

“[…] As of the end of last year, their total reserves were 438 million barrels equivalent, that was up 16% year over year, that’s absolutely huge. They keep finding more and more oil or natural gas. Now, the company’s production, the numbers were off the chain, they just got better and better every single day last year. That’s a trend they have brought into this year, in fact, recently they got the production expectations for the whole year higher. Earnings estimates, they have been gradually moving up also over the last three months and I think, in the next two quarters the Street is feeling much better about them […],” Payne said.

Payne also feels that Whiting Petroleum Corp (NYSE:WLL) acquisition of Kodiak Oil & Gas Corp (NYSE:KOG) is going to be good for the company. He expects Whiting Petroleum Corp (NYSE:WLL)’s stock to reach levels of $110. McCall agreed with Payne, he finds all the natural companies attractive right now. According to McCall, when Whiting Petroleum Corp (NYSE:WLL)’s acquisition of Kodiak Oil & Gas Corp (NYSE:KOG) is complete, the joint entity would have better bargaining power. He feels that if someone wants to invest in natural gas companies, Whiting Petroleum Corp (NYSE:WLL)  is one of the best bets. David Nelson agreed with them both and feels that Whiting Petroleum Corp (NYSE:WLL) ‘s growth is quite impressive.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!